These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 15346996)
1. Greater risks of chemotherapy toxicity in elderly patients with cancer. Repetto L J Support Oncol; 2003; 1(4 Suppl 2):18-24. PubMed ID: 15346996 [TBL] [Abstract][Full Text] [Related]
2. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. Dale DC J Support Oncol; 2003; 1(4 Suppl 2):11-7. PubMed ID: 15346995 [TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
4. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy. Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197 [TBL] [Abstract][Full Text] [Related]
5. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients. Garg P; Rana F; Gupta R; Buzaianu EM; Guthrie TH Breast J; 2009; 15(4):404-8. PubMed ID: 19508671 [TBL] [Abstract][Full Text] [Related]
6. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N; Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy. Hamberg P; Verweij J; Seynaeve C Eur J Cancer; 2007 Jul; 43(10):1514-28. PubMed ID: 17482454 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factors: finding the right indication. Lyman GH; Shayne M Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791 [TBL] [Abstract][Full Text] [Related]
9. [Effective treatment strategy in elderly breast cancer patients]. Boér K Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Crawford J; Dale DC; Lyman GH Cancer; 2004 Jan; 100(2):228-37. PubMed ID: 14716755 [TBL] [Abstract][Full Text] [Related]
11. New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care. Balducci L J Support Oncol; 2003; 1(4 Suppl 2):30-7. PubMed ID: 15346998 [TBL] [Abstract][Full Text] [Related]
12. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ; Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590 [TBL] [Abstract][Full Text] [Related]
13. Lung cancer in the elderly. Gridelli C; Langer C; Maione P; Rossi A; Schild SE J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989 [TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872 [TBL] [Abstract][Full Text] [Related]
15. Supportive care in elderly cancer patients. Balducci L Curr Opin Oncol; 2009 Jul; 21(4):310-7. PubMed ID: 19412099 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology and organ toxicity of chemotherapy in older patients. Balducci L; Mowry K Oncology (Williston Park); 1992 Feb; 6(2 Suppl):62-8. PubMed ID: 1532739 [TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey. Repetto L; Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660 [TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions? Klepin HD; Hurd DD Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209 [TBL] [Abstract][Full Text] [Related]
19. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses. Kearney N; Friese C Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720 [TBL] [Abstract][Full Text] [Related]
20. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF; Chan HO Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]